Triazoles useful as inhibitors of protein kinases

Details for Australian Patent Application No. 2005299816 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Wang, Jian; Arnost, Michael J.; Forster, Cornelia J.; Davies, Robert J.

Agent Cullens

Pub. Number AU-B-2005299816

PCT Pub. Number WO2006/047256

Priority 60/621,270 21.10.04 US

Filing date 21 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 1 September 2011

International Classifications

C07D 249/14 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/047256 Priority application(s): WO2006/047256

5 July 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 05 Jun 2007

1 September 2011 Application Accepted

  Published as AU-B-2005299816

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299822-4 [(2,4-dichloro-5-methoxyphenyl)amino]- 6-alkoxy-7-ethynyl-3-quinolinecarbonitril es for the treatment of ischemic injury

2005299809-Anti-IL-22RA antibodies and binding partners and methods of using in inflammation